Dyslipidemias: all 1,101 studies

Page 10 of 12. Open to participants first (161), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Motivational Interview in Patients With DyslipidemiaCompletedNCT01282190Not applicable
• Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of PatientsCompletedNCT01278693Phase 2
• Dyslipidemia Treatment in Thailand and Cardiovascular OutcomesWithdrawnNCT01265836
• Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With DiabetesCompletedNCT01264263
• Africa and Middle East Cardiovascular Epidemiological StudyCompletedNCT01243138
• Colesevelam Treatment for Impaired Fasting Glucose During Niacin TherapyCompletedNCT01239004Phase 4
• Centralized Pan-Russian Survey on the Undertreatment of HypercholesterolemiaCompletedNCT01221584
• Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed DyslipidemiaCompletedNCT01216956Not applicable
• A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South AsiaStatus unknownNCT01212328Not applicable
• Efficacy Study of Diazoxide Choline to Treat HypertriglyceridemiaCompletedNCT01211847Phase 2
• Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) KineticsCompletedNCT01205750Not applicable
• Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 WeeksCompletedNCT01165853Not applicable
• Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in OutpatientsCompletedNCT01164397
• Multiple-Dose Safety Study Of RN316 For TheTreatment Of HypercholesterolemiaWithdrawnNCT01163838Phase 1
• Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)CompletedNCT01122667Phase 1
• Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)CompletedNCT01114490Phase 1
• Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic PatientsCompletedNCT01113099Not applicable
• Safety Study of BMS-823778 in Subjects With HypercholesterolemiaCompletedNCT01112423Phase 2
• A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)CompletedNCT01104519Phase 1
• The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two WeeksCompletedNCT01103921Not applicable
• A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)CompletedNCT01101763
• The Effects of Hypolipemic and Antidiabetic Treatment on CytokinesStatus unknownNCT01101204Not applicable
• Study of Undertreatment of Patients With Dyslipidemia in BulgariaCompletedNCT01075594
• Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)CompletedNCT01071291Phase 1
• Study of A3309 in Patients With DyslipidemiaCompletedNCT01069783Phase 2
• Additional KIF6 Risk Offers Better Adherence to StatinsCompletedNCT01068834
• Safety Study of BMS-770767 in Subjects With HypercholesterolemiaCompletedNCT01058083Phase 2
• Statin Therapy Results in the Real World Practice in the Czech RepublicCompletedNCT01055977
• The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac PatientsTerminatedNCT01052311Phase 4
• Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take StatinsCompletedNCT01047176
• Dyslipidemia in Cardiovascular DiseaseCompletedNCT01029522Phase 4
• Resistant Starch Insulin Sensitivity TrialCompletedNCT01027325Not applicable
• Observational Study To Evaluate Statins Patterns Of Use In SpainWithdrawnNCT01023503
• Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With PsoriasisCompletedNCT01019200
• Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed HyperlipidemiaStatus unknownNCT01010516Phase 4
• The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)CompletedNCT00990808Phase 1
• Safety Study of BMS-816336 in Healthy Male SubjectsCompletedNCT00979368Phase 1
• A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)CompletedNCT00977288Phase 2
• Reduce Obesity and DiabetesStatus unknownNCT00954577
• The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal WomenStatus unknownNCT00945217
• Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With OlanzapineWithdrawnNCT00934908Not applicable
• Cardioprotective Effects of Green Tea Versus Maté IntakeStatus unknownNCT00933647Phase 3
• Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean PatientsCompletedNCT00931320
• Nutrition and Exercise Intervention StudyStatus unknownNCT00926744Not applicable
• Production of Free Fatty Acids From Blood TriglyceridesCompletedNCT00911482
• Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)CompletedNCT00895141Not applicable
• Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or DyslipidemiaCompletedNCT00879125
• Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)CompletedNCT00861861Phase 4
• Association of Genes to Resistance to Weight Loss in Obese PatientsCompletedNCT00858221
• Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic PatientsCompletedNCT00854503Phase 3
• Lipoprotein Effects of Substituting Beef Protein for CarbohydrateCompletedNCT00852267Not applicable
• Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial PeriodCompletedNCT00845637Phase 1
• Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With StatinsCompletedNCT00829348Not applicable
• Repeat Dose Food Effect Study of GSK256073F in Healthy Adult SubjectsCompletedNCT00808093Phase 1
• A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.CompletedNCT00783549Phase 1
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL CholesterolCompletedNCT00768274Phase 1/2
• Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C LevelsCompletedNCT00749788Phase 2
• Safety Study of JTT-302 in Subjects With Low HDL-C LevelsCompletedNCT00748852Phase 2
• The Healthy Options Feasibility StudyCompletedNCT00746460Not applicable
• Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)CompletedNCT00726856
• Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)Status unknownNCT00712049Phase 4
• A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.CompletedNCT00708370Phase 4
• MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)TerminatedNCT00703690Phase 2
• National Survey on Dyslipidemic PatientsCompletedNCT00701402
• Change in Plaque Characteristics With AtorvastatinCompletedNCT00700037Phase 4
• Risk Assessment and Treat Compliance in Hypertension Education TrialCompletedNCT00694239Not applicable
• Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsCompletedNCT00689442Phase 2
• Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsCompletedNCT00688558Phase 2
• Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in ThailandCompletedNCT00684151
• Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk FactorsCompletedNCT00666250Not applicable
• Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese WomenCompletedNCT00666172Phase 2
• Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary SyndromeCompletedNCT00665834Phase 4
• Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)WithdrawnNCT00664287Phase 3
• Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and HyperlipidemiaCompletedNCT00663845Phase 4
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic SyndromeCompletedNCT00659321Phase 3
• 48-wk Open Label Phase IIIb to Evaluate Efficacy and SafetyCompletedNCT00654602Phase 3
• IIIb 6 Week Open Label Multicentre Rosuvastatin & SimvastatinCompletedNCT00654446Phase 3
• Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)CompletedNCT00654225Phase 3
• Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)CompletedNCT00653965Phase 3
• Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)CompletedNCT00653744Phase 3
• Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)CompletedNCT00651963Phase 4
• Atorvastatin Study For The Treatment Of High Cholesterol In Patients From ThailandCompletedNCT00647543Phase 4
• Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic SyndromeCompletedNCT00645775Not applicable
• A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High CholesterolCompletedNCT00645151Phase 4
• A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)CompletedNCT00644709Phase 4
• A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High CholesterolCompletedNCT00644670Phase 4
• Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM)CompletedNCT00634673Not applicable
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy HumansCompletedNCT00625170Not applicable
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy HumansCompletedNCT00625014Not applicable
• Fenofibrate and Pharmacogenetic Impact in DyslipidemiaCompletedNCT00613613
• A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy VolunteersCompletedNCT00608699Phase 1
• TTA in Treatment of Diabetes and DyslipidemiaCompletedNCT00605787Phase 2
• LDL-Cholesterol Lowering Effect of KB2115 as Add on to StatinCompletedNCT00593047Phase 2
• Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedNCT00585143Phase 1
• Improved Delivery of Cardiovascular Care Through Outreach FacilitationCompletedNCT00574808Phase 1
• Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of DyslipidemiaCompletedNCT00557778
• Complications in Hypertension and ObesityStatus unknownNCT00552292
• A Second Study to Determine the Effect of GSK256073A on HVTsCompletedNCT00551694Phase 1
• Dyslipidemia in Type 2 Diabetes (0767-034)TerminatedNCT00547274Phase 3
• Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and DyslipidemiaStatus unknownNCT00541554Phase 4

← Dyslipidemias overview